gemcitabine has been researched along with liquiritigenin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, ZQ; Luo, RJ; Wu, W; Xia, Q; Xue, P | 1 |
1 other study(ies) available for gemcitabine and liquiritigenin
Article | Year |
---|---|
In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS- Mediated Signalling Pathways.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Apoptosis; Capillary Leak Syndrome; Cell Line, Tumor; Cell Survival; Deoxycytidine; Electric Impedance; Flavanones; Gemcitabine; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 9; Pancreatic Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; rac1 GTP-Binding Protein; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53; Vascular Cell Adhesion Molecule-1 | 2015 |